EFFECT OF COMBINED THERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS, INTERLEUKIN-2 AND SPECIFIC MONOCLONAL-ANTIBODY ON ESTABLISHED B-16 MELANOMA LUNG METASTASES

被引：0
|
作者：
EISENTHAL, A
CAMERON, RB
UPPENKAMP, I
ROSENBERG, SA
机构：
来源：
CANCER RESEARCH | 1988年 / 48卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7140 / 7145
页数：6
相关论文
共 50 条
  • [1] TREATMENT OF ESTABLISHED B-16 MELANOMA LUNG METASTASES WITH LAK CELLS AND ANTI B-16 MELANOMA MONOCLONAL-ANTIBODY
    EISENTHAL, A
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 428 - 428
  • [2] THE EFFECT OF ANTI B-16 MELANOMA MONOCLONAL-ANTIBODY ON ESTABLISHED MURINE B-16 MELANOMA LIVER METASTASES
    EISENTHAL, A
    LAFRENIERE, R
    LEFOR, AT
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 384 - 384
  • [3] MONOCLONAL-ANTIBODY THERAPY OF MURINE LYMPHOMA - ENHANCED EFFICACY BY CONCURRENT ADMINISTRATION OF INTERLEUKIN-2 OR LYMPHOKINE-ACTIVATED KILLER-CELLS
    SCHULTZ, KR
    KLARNET, JP
    PEACE, DJ
    CHEEVER, MA
    BADGER, CC
    BERNSTEIN, ID
    GREENBERG, PD
    CANCER RESEARCH, 1990, 50 (17) : 5421 - 5425
  • [4] EFFECT OF ANTI-B16 MELANOMA MONOCLONAL-ANTIBODY ON ESTABLISHED MURINE B-16 MELANOMA LIVER METASTASES
    EISENTHAL, A
    LAFRENIERE, R
    LEFOR, AT
    ROSENBERG, SA
    CANCER RESEARCH, 1987, 47 (11) : 2771 - 2776
  • [5] TREATMENT WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
    DEGOS, L
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (1-2): : 119 - 122
  • [6] EFFECT OF IMMUNOTHERAPY WITH ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 ON ESTABLISHED PULMONARY AND HEPATIC METASTASES IN MICE
    SHILONI, E
    LAFRENIERE, R
    MULE, JJ
    SCHWARZ, SL
    ROSENBERG, SA
    CANCER RESEARCH, 1986, 46 (11) : 5633 - 5640
  • [7] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [8] THE ANTITUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 INVIVO - DIRECT CORRELATION BETWEEN REDUCTION OF ESTABLISHED METASTASES AND CYTOLYTIC ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    MULE, JJ
    YANG, J
    SHU, SY
    ROSENBERG, SA
    JOURNAL OF IMMUNOLOGY, 1986, 136 (10): : 3899 - 3909
  • [9] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
  • [10] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY FOR GASTROINTESTINAL CANCER
    GUILLOU, P
    ACTA CHIRURGICA SCANDINAVICA, 1989, : 26 - 30
12345